Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: Results from the Cilostazol for RESTenosis (CREST) trial-Reference-Cited by-同舟云学术

Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: Results from the Cilostazol for RESTenosis (CREST) trial

Published:2006-10 Issue:4 Volume:152 Page:770-776
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Zhang Zefeng,Foster Jovonne K.,Kolm Paul,Jurkovitz Claudine T.,Parker Karen M.,Murrah Nancy V.,Anderson Grant T.,Douglas John S.,Weintraub William S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months;Serruys;Circulation,1988

2. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease;Serruys;N Engl J Med,1994

3. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease;Fischman;N Engl J Med,1994

4. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials;Cutlip;J Am Coll Cardiol,2002

5. Acute and long-term outcome after Palmaz-Schatz stenting: analysis from the New Approaches to Coronary Intervention (NACI) registry;Carrozza;Am J Cardiol,1997

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterases in heart and vessels- From Physiology to Diseases;Physiological Reviews;2023-11-16

2. Update on Cilostazol: A Critical Review of Its Antithrombotic and Cardiovascular Actions and Its Clinical Applications;The Journal of Clinical Pharmacology;2021-11-25

3. Treatment of In-Stent Stenosis Following Flow Diversion of Intracranial Aneurysms with Cilostazol and Clopidogrel;Neurointervention;2021-11-01

4. Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury;Proceedings of the National Academy of Sciences;2015-04-15

5. Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy for patients undergoing PCI: a meta-analysis of randomized trials with adjusted indirect comparisons;Current Medical Research and Opinion;2013-10-18